Supplies Still Limited More Than a Year After Monoclonal Antibodies Authorized for Treating COVID-19 From The Reputable Epic Times By Meiling Lee January 6, 2022 Despite being the only authorized outpatient medical therapy for preventing the worsening of COVID-19 symptoms in high-risk patients, there remains no steady supply of monoclonal antibodies from the federal government a year...